Catalyst Wire Dossier Catalyst Wire Dossier

VISIPAQUE

IODIXANOL · GE Healthcare Inc.
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for VISIPAQUE, covering 2006-11-30 to 2023-04-25. Get the full timeline:

Most recent: FDA Approved: VISIPAQUE — Supplemental Application (GE Healthcare Inc.)

See pricing